Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Operating Activities:
Net income	$ 14,816,000	$ 23,376,000
Adjustments to reconcile net income from operations to net cash rovided by operating activities:
Provision for credit losses	91,602,000	70,499,000
Losses on claims for payment protection plan	6,745,000	5,249,000
Depreciation and amortization	2,407,000	2,070,000
Amortization of debt issuance costs	163,000	155,000
Loss on disposal of property and equipment	76,000	64,000
Stock based compensation	1,147,000	1,525,000
Deferred income taxes	(1,817,000)	1,784,000
Change in operating assets and liabilities:
Finance receivable originations	(308,330,000)	(284,931,000)
Finance receivable collections	155,481,000	144,025,000
Accrued interest on finance receivables	(136,000)	(506,000)
Inventory	31,427,000	19,283,000
Prepaid expenses and other assets	(868,000)	(642,000)
Accounts payable and accrued liabilities	2,001,000	2,806,000
Deferred payment protection plan revenue	754,000	1,614,000
Income taxes, net	3,028,000	(463,000)
Excess tax benefit from share based compensation	(120,000)	(99,000)
Net cash used in operating activities	(1,624,000)	(14,191,000)
Investing Activities:
Purchases of property and equipment	(5,541,000)	(3,438,000)
Proceeds from sale of property and equipment	2,000	199,000
Net cash used in investing activities	(5,539,000)	(3,239,000)
Financing Activities:
Exercise of stock options and warrants	719,000	665,000
Excess tax benefit from share based compensation	120,000	98,000
Issuance of common stock	152,000	143,000
Purchase of common stock	(8,739,000)	(17,248,000)
Dividend payments	(30,000)	(30,000)
Debt issuance costs	(200,000)	(56,000)
Change in cash overdrafts	149,000	3,017,000
Proceeds from revolving credit facilities	237,263,000	238,336,000
Payments on revolving credit facilities	(222,287,000)	(206,906,000)
Net cash provided by financing activities	7,147,000	18,019,000
Increase (decrease) in cash and cash equivalents	(16,000)	589,000
Cash and cash equivalents, beginning of period	272,000	276,000
Cash and cash equivalents, end of period	$ 256,000	$ 865,000